Hormone Replacement Therapy and Circulating ICAM-1 in Postmenopausal Women
- 1 January 1999
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 81 (05) , 673-675
Abstract
Summary: Hormone replacement therapy may reduce the risk of coronary heart disease but underlying mechanism has not been adequately explained. Recent data suggest that intercellular adhesion molecule 1 (ICAM-1) plays a critical role in early stage of atherosclerosis and may serve as a molecular marker for the development of arterial disease. We investigated the effects of oral and transdermal cyclic oestradiol combined with progesterone on plasma concentration of soluble ICAM-1 (sICAM-1). Thirty-seven healthy postmenopausal women were randomly assigned to receive either oral estradiol valerate or transdermal estradiol both combined with micronized progesterone or no hormonal treatment. Plasma sICAM-1 was assayed at baseline and after a 6-month period. Oral but not transdermal estradiol regimen significantly decreased mean value of sICAM-1 compared with no treatment. Differences in sICAM-1 levels between active treatments were significant. There were no significant changes in mean values of fibrinogen between the three groups. Our results show a favorable effect of oral estrogen plus progesterone on a soluble marker of vascular inflammation and may provide plausible explanation for a cardioprotective effect of hormone replacement therapy among healthy postmenopausal women.Keywords
This publication has 5 references indexed in Scilit:
- Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy menThe Lancet, 1998
- Effects of Hormone Therapy on Inflammatory Cell Adhesion Molecules in Postmenopausal Healthy WomenThe American Journal of Cardiology, 1997
- Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal womenThe Lancet, 1994
- Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.Journal of Clinical Investigation, 1993
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957